Opinion: Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation

Following the money leads to one of the best ways to turn around the problem of underrepresentation in clinical trials: financial incentives.

The lack of diversity in clinical trials unfairly skews American medicine and costs billions of dollars a year in early deaths and poor health. Proven economic incentives to recruit more diverse participants can dramatically change the picture — if the will exists to employ them.

The scope of the problem was laid out in a new report that Congress requested from the National Academies of Sciences, Engineering, and Medicine, which we as committee members helped write.

Read the rest…